Long-Term Effects of Xanax: Risks to Brain and Body

Long-term use of Xanax (alprazolam) reshapes how the brain processes calm, fear, and memory, and the consequences extend well beyond the nervous system. Even at prescribed doses, months or years of daily use can impair memory, alter sleep quality, increase fall risk, and set the stage for a withdrawal syndrome that some people describe as worse than the anxiety the drug was meant to treat. The picture is further complicated by ongoing scientific debate about whether benzodiazepines raise the risk of dementia, and by accumulating evidence that the drug’s effects on the body reach the gut, the hormonal system, and brain structures involved in emotion and learning.

How Tolerance Develops and Why It Matters

Xanax works by enhancing the activity of GABA, the brain’s main inhibitory neurotransmitter. When you take the drug regularly, the brain begins to compensate. GABA receptor subunits change their expression, the coupling between receptors and their downstream signals weakens, and excitatory systems involving glutamate ramp up to counterbalance the constant sedation. The serotonin, dopamine, acetylcholine, and neurosteroid systems also shift in response.

1PubMed Central. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

These neuroadaptive changes do not happen at the same rate in every brain system. Tolerance to sedation often develops within days to weeks, while tolerance to the anti-anxiety effects may take much longer or never fully develop. This uneven timeline is part of what makes long-term Xanax use so tricky: you may need more of the drug to feel sleepy, but a higher dose now carries greater risk to memory and coordination without proportionally more anxiety relief.

Alprazolam stands out among benzodiazepines for its rapid onset and short half-life, traits that many addiction specialists believe give it a higher potential for misuse. It hits fast, wears off fast, and the rebound discomfort between doses reinforces the urge to take more. Despite this, it remains one of the most widely prescribed benzodiazepines, a disconnect between how primary care physicians use it and how addiction medicine views it.

What Happens to Memory and Thinking

Memory impairment is one of the most consistently documented effects of long-term Xanax use. In a controlled study of healthy male volunteers, just two weeks of daily alprazolam produced measurable declines in visual memory and delayed recall compared to a placebo group. Psychomotor speed and attention were not affected at that point, but the learning deficits were clear: people on the drug had significantly more trouble storing and retrieving new information.

2PubMed Central. The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers

In older adults who had been dependent on benzodiazepines for years, the damage looks more severe. A study comparing detoxified benzodiazepine-dependent patients with both alcohol-dependent patients and healthy controls found that the benzodiazepine group had significantly more trouble with learning, short-term recall, and delayed recall, and these deficits persisted into the early drug-free period.

3PubMed. Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients

A meta-analysis looking at cognitive function after benzodiazepine withdrawal found that while many areas of thinking do improve, former long-term users still showed significant cognitive impairment compared to controls at least six months after stopping. The authors noted that full recovery might take longer than six months or might not happen completely in some people.

4Archives of Clinical Neuropsychology. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis

There is some good news buried in the data. A 3.5-year follow-up study of patients who had taken alprazolam for panic disorder found that their objective memory performance eventually returned to pre-treatment levels and matched that of former placebo patients. The catch was subjective: former alprazolam users still rated themselves as less attentive, less clear-headed, and clumsier than those who had taken a placebo, suggesting that even after measurable recovery, the experience of having been cognitively impaired leaves a mark on self-perception.

5PubMed. Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients

The Dementia Question

Whether benzodiazepines cause dementia is one of the most debated questions in geriatric medicine, and the evidence genuinely points in different directions depending on which study you look at. A meta-analysis of ten observational studies found that people who had ever used benzodiazepines had roughly a 50% higher risk of developing dementia compared to those who had never used them.

6PubMed Central. Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies

Data-mining analyses of adverse event databases in the United States and Canada have pointed in a similar direction, finding associations that grew stronger with longer-acting benzodiazepines and with longer durations of use.

7PubMed Central. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases

But a large population-based study with over 5,000 participants followed for an average of eleven years came to a more nuanced result. Overall, benzodiazepine use was not associated with dementia risk. However, high cumulative doses of anxiolytic benzodiazepines specifically (the category Xanax falls into) did show a modestly elevated risk. Brain imaging in that same study found that current benzodiazepine users had smaller hippocampal, amygdala, and thalamic volumes and faster hippocampal shrinkage over time, though these structural changes did not clearly differ by drug type or cumulative dose.

8PubMed Central. Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study

The honest read of the evidence is that benzodiazepines probably do not directly cause Alzheimer’s disease the way amyloid plaques do, but long-term use appears to accelerate brain volume loss in memory-critical regions and may increase dementia risk through that and other pathways. The confounding problem is enormous here: people prescribed Xanax for years often have chronic anxiety, insomnia, or depression, all of which are themselves linked to cognitive decline. Separating the drug’s effect from the disease it treats is something the current data cannot do cleanly.

How Long-Term Use Disrupts Sleep

It sounds paradoxical that a drug often prescribed for insomnia can damage sleep quality, but the evidence is consistent. Benzodiazepines increase the lighter stage of sleep (stage 2 of NREM sleep) while reducing the deeper, restorative stages (stages 3 and 4) and cutting into REM sleep time.

9PubMed. Benzodiazepines and Sleep Architecture: A Systematic Review

In people with severe benzodiazepine dependence, polysomnography shows the damage in finer detail: time in bed and the latency before REM sleep both increase, the proportion of the lightest sleep stage rises, and the delta-band power during NREM sleep drops dramatically. Delta activity is the brain’s signature of deep, physically restorative sleep, and its suppression means that even though a long-term Xanax user may be unconscious for seven or eight hours, the sleep they are getting is shallow and less restful than it should be.

10PubMed. Sleep architecture in insomniacs with severe benzodiazepine abuse

This matters beyond just feeling tired. Deep sleep is when the brain consolidates memories, clears metabolic waste products, and repairs itself. Chronic suppression of deep sleep may contribute to the cognitive problems described earlier and could theoretically play a role in the accelerated brain volume loss seen in imaging studies of long-term users.

Withdrawal, Rebound, and Protracted Symptoms

Stopping Xanax after long-term use triggers a withdrawal syndrome that follows a few recognizable patterns. The most common is a short-lived rebound of anxiety and insomnia within one to four days of the last dose (faster with short-acting drugs like alprazolam). The second pattern is a full withdrawal syndrome lasting roughly ten to fourteen days, which can include sleep disturbance, irritability, panic attacks, tremor, sweating, concentration problems, nausea, palpitations, headache, muscle pain, and various perceptual disturbances. The third pattern is the return of the original anxiety symptoms.

11PubMed. The benzodiazepine withdrawal syndrome

What catches many people off guard is the existence of a protracted withdrawal syndrome. Symptoms from the first week of discontinuation can merge with more persistent problems lasting months or, in some reports, longer. These prolonged symptoms often include anxiety that may partly result from a learning deficit the drugs imposed, along with various sensory and motor neurological symptoms. The slow, uneven pace at which different brain systems recover from tolerance helps explain why some symptoms resolve quickly while others linger. Some researchers have raised the possibility that very long-term benzodiazepine use could cause not just slowly reversible functional changes in the nervous system, but occasionally structural damage to neurons.

12Journal of Substance Abuse Treatment. Protracted withdrawal syndromes from benzodiazepines

One proposed mechanism for why protracted withdrawal becomes self-sustaining involves oxidative stress pathways. The hypothesis suggests that benzodiazepine withdrawal can trigger elevated levels of peroxynitrite, a potent oxidant, through overactivation of calcium channels and glutamate receptors. Once this oxidative cycle starts, it may perpetuate symptoms and reduced GABA receptor function, possibly explaining why some former users develop chronic conditions resembling chronic fatigue syndrome or fibromyalgia.

13PubMed. How chronic administration of benzodiazepines leads to unexplained chronic illnesses: A hypothesis

The Overdose Risk When Combined With Opioids

Xanax alone rarely kills in overdose unless combined with other central nervous system depressants, and the most dangerous combination is benzodiazepines with opioids. Both drug classes suppress breathing, and the combination is more than additive in its effect on respiratory drive. A retrospective cohort study found a significant increase in overdose risk among patients taking opioids together with benzodiazepines or other sedative-hypnotics compared to those taking opioids alone, with the elderly, people with a history of overdose, and those with substance use disorders at greatest risk.

14PubMed Central. Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study

Polypharmacy is common among people who take prescription opioids long-term, and co-dispensing of interacting medications further increases overdose risk.

15PubMed. Coprescription of Opioids With Other Medications and Risk of Opioid Overdose

If you are prescribed both an opioid and Xanax (or any benzodiazepine), this is a conversation worth having with your prescriber. The FDA added a black-box warning to both drug classes about this risk years ago, but co-prescribing remains common in practice.

Effects on Stress Hormones

Alprazolam suppresses the hypothalamic-pituitary-adrenal (HPA) axis, the hormonal system that governs your stress response. It does this by dampening the release of corticotropin-releasing hormone and related signaling molecules in the brain, which in turn reduces cortisol output. Research has shown that alprazolam can override even strong stimulatory signals to the HPA axis, suppressing the cortisol response even when the normal feedback loop is blocked experimentally.

16The Journal of Clinical Endocrinology & Metabolism. The Inhibitory Effect of Alprazolam, a Benzodiazepine, Overrides the Stimulatory Effect of Metyrapone-Induced Lack of Negative Cortisol Feedback on Corticotroph Secretion in Humans

This has a practical implication that is rarely discussed with patients: long-term suppression of the HPA axis could blunt your ability to mount an appropriate cortisol response to physical stress, illness, or surgery. Researchers have noted that this makes alprazolam potentially problematic for anyone with suspected adrenal insufficiency. And for otherwise healthy long-term users, chronically low cortisol may contribute to fatigue, difficulty handling stress, and a sense that something feels “off” beyond the anxiety the drug is treating.

Why Older Adults Face Greater Risks

The risks of long-term Xanax use are amplified in people over 65. Falls are a major concern: benzodiazepines impair balance, coordination, and reaction time, and in older adults a fall can mean a broken hip and a cascade of complications. Cognitive impairment in this population is more pronounced and harder to distinguish from early dementia. Sedation is deeper and longer-lasting because older adults metabolize the drug more slowly, and driving ability suffers.

17PubMed. Safety of benzodiazepines in the geriatric population

The American Geriatrics Society’s Beers Criteria has listed benzodiazepines as potentially inappropriate for older adults for years. Despite this, prescription rates in this age group remain stubbornly high, often because the drugs were started years earlier and neither the patient nor the prescriber has revisited the decision.

Can the Brain Recover After Stopping

Recovery is possible, but it is neither guaranteed nor always complete. A scoping review of long-term neurological consequences found that benzodiazepine patients tested before tapering showed impaired intelligence and nonverbal memory compared to healthy controls, but when retested a year later, their scores had improved to levels similar to controls, suggesting that neurological deficits are at least partly reversible with enough time.

18PLoS One. Long-term neurological consequences following benzodiazepine exposure: A scoping review

The meta-analysis cited earlier paints a more cautious picture: many cognitive domains improve after withdrawal, but significant impairments relative to never-users can persist for at least six months, and the data cannot confirm whether full restitution eventually occurs for everyone.

4Archives of Clinical Neuropsychology. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis

Taken together, the evidence says that the brain does heal, but slowly and perhaps incompletely. The earlier you stop and the shorter the duration of use, the better the odds of full recovery. For people who have been on benzodiazepines for decades, some residual cognitive effects may be the cost of those years on the drug.

How to Taper Safely

Abruptly stopping Xanax after long-term use is dangerous. It can trigger seizures, severe rebound anxiety, and in rare cases, life-threatening complications. A joint clinical practice guideline published in 2025 by the American Society of Addiction Medicine and nine other medical organizations emphasizes several principles: clinicians should conduct ongoing risk-benefit assessments, use shared decision-making, never abruptly discontinue in patients who are likely physically dependent, tailor the taper to the individual and adjust based on response, and offer psychosocial support alongside the taper.

19PubMed Central. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits

Cognitive behavioral therapy plays a meaningful role in the process. Studies have found that adding CBT to a structured taper can raise abstinence success rates to the range of 70 to 80 percent, compared to lower rates with a taper alone.

20PubMed Central. Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders

For people with panic disorder specifically, an exposure-based form of CBT designed to address the fear of withdrawal sensations has demonstrated specific efficacy in preventing relapse and facilitating successful discontinuation, with benefits that grow over time and reach significance by six months after the taper ends.

21PubMed Central. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation

Effects on the Gut Microbiome

An emerging area of research has found that benzodiazepines, among other non-antibiotic medications, leave a measurable footprint on the gut microbiome that persists even after the drugs are discontinued. Researchers studying large population cohorts identified carryover and additive effects on gut bacteria from benzodiazepine derivatives, antidepressants, and glucocorticoids, meaning that the microbial communities in your intestines may still reflect drug use from years earlier. The practical consequences of these microbial shifts are not yet clear, but given the growing evidence linking gut bacteria to mood regulation, immune function, and inflammation, this is a finding worth watching.

Pregnancy and Fetal Exposure

Using Xanax during pregnancy raises distinct concerns. Animal studies suggest that early exposure to benzodiazepines can influence developing neurotransmitter systems, neuronal structure, and behavior in offspring. Observational studies in humans have found associations between prenatal benzodiazepine exposure and certain neonatal and developmental outcomes, though results are inconsistent and tangled up with confounders like maternal mental illness and co-medications. The research has not yet identified clear dose thresholds, critical windows of vulnerability, or reliable predictions about long-term effects on children. What is clear is that the question remains open and that anyone taking Xanax who becomes pregnant or is planning a pregnancy should discuss the risks with their prescriber, since both untreated anxiety and benzodiazepine exposure carry their own developmental considerations.